Market closed · Oct 8, 5:40 am ET · Last extended-hours $20.29 0.00%
Open$19.67
Prev close$20.03
Day range$19.67 – $20.72
Volume121.1K
Market cap$662.35M
P/E (TTM)–
Dividend yield–
NVCT Stock News
Headlines matching Nuvectis Pharma or the NVCT ticker, most recent first.
Maxim Group Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Maintains Target Price $30Market news · 26 Sep 2026 · Direct mention
H.C. Wainwright Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Maintains Target Price $39Market news · 24 Sep 2026 · Direct mention
Lucid Capital Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Raises Target Price to $34PositiveMarket news · 5 Aug 2026 · Direct mention
Cantor Fitzgerald Initiates Nuvectis Pharma(NVCT.US) With Buy RatingMarket news · 24 Aug 2026 · Direct mention
Roth MKM Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Maintains Target Price $33Market news · 6 Jul 2026 · Direct mention
Roth MKM Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Raises Target Price to $33PositiveMarket news · 6 Jul 2026 · Direct mention
Maxim Group Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Raises Target Price to $30PositiveMarket news · 24 Jun 2026 · Direct mention
Lucid Capital Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Raises Target Price to $22PositiveMarket news · 23 Jun 2026 · Direct mention
H.C. Wainwright Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Raises Target Price to $39PositiveMarket news · 22 Jun 2026 · Direct mention
H.C. Wainwright Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Maintains Target Price $13Market news · 15 Jun 2026 · Direct mention
H.C. Wainwright Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Raises Target Price to $13PositiveMarket news · 13 Jun 2026 · Direct mention
Maxim Group Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Maintains Target Price $17Market news · 11 Jun 2026 · Direct mention
H.C. Wainwright Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Maintains Target Price $10Market news · 5 May 2026 · Direct mention
Analysts Offer Insights on Healthcare Companies: Nuvectis Pharma (NVCT), Tenet Healthcare (THC) and Upstream Bio, Inc. (UPB)TipRanks · 12 Feb 2026 · Direct mention
H.C. Wainwright Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Cuts Target Price to $10NegativeMarket news · 4 Aug 2025 · Direct mention
Discussion
No comments yet — be the first to weigh in on NVCT.
No comments yet — be the first to weigh in on NVCT.